• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

糖尿病肾病：现状与未来治疗前景。

Diabetic kidney disease: Its current trends and future therapeutic perspectives.

机构信息

Department of Diabetology and Endocrinology, Division of Anticipatory Molecular Food Science and Technology, Kanazawa Medical University, Ishikawa, Japan.

出版信息

J Diabetes Investig. 2019 Sep;10(5):1174-1176. doi: 10.1111/jdi.13121. Epub 2019 Aug 22.

DOI:10.1111/jdi.13121
PMID:31361399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6717829/
Abstract

Diabetic kidney disease.[Image: see text]

摘要

糖尿病肾病。[图片：见正文]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858f/6717829/d97cd92d7902/JDI-10-1174-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858f/6717829/d97cd92d7902/JDI-10-1174-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858f/6717829/d97cd92d7902/JDI-10-1174-g001.jpg

相似文献

1
Diabetic kidney disease: Its current trends and future therapeutic perspectives.糖尿病肾病：现状与未来治疗前景。
J Diabetes Investig. 2019 Sep;10(5):1174-1176. doi: 10.1111/jdi.13121. Epub 2019 Aug 22.
2
[Diabetes management issues for patients with chronic kidney disease].[慢性肾脏病患者的糖尿病管理问题]
Nephrol Ther. 2012 Jun;8(3):135-40. doi: 10.1016/j.nephro.2011.07.410. Epub 2011 Oct 20.
3
Novel hypoglycaemic agents: considerations in patients with chronic kidney disease.新型降糖药物：慢性肾脏病患者的考虑因素。
Nephron Clin Pract. 2014;126(1):14-8. doi: 10.1159/000357680. Epub 2014 Jan 11.
4
Do effects of sodium-glucose cotransporter-2 inhibitors in patients with diabetes give insight into potential use in non-diabetic kidney disease?钠-葡萄糖协同转运蛋白2抑制剂对糖尿病患者的疗效能否为其在非糖尿病肾病中的潜在应用提供线索？
Curr Opin Nephrol Hypertens. 2017 Sep;26(5):358-367. doi: 10.1097/MNH.0000000000000343.
5
[Newer anti - diabetic therapies and chronic kidney disease].[新型抗糖尿病疗法与慢性肾脏病]
G Ital Nefrol. 2017 Jan-Feb;34(1).
6
Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus and chronic kidney disease.2型糖尿病合并慢性肾脏病患者的心血管及全因死亡率
J Diabetes Complications. 2017 Mar;31(3):646. doi: 10.1016/j.jdiacomp.2016.09.004. Epub 2016 Sep 18.
7
Response to cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus and chronic kidney disease.2型糖尿病合并慢性肾脏病患者心血管及全因死亡率的应对情况
J Diabetes Complications. 2017 Mar;31(3):647. doi: 10.1016/j.jdiacomp.2016.12.005. Epub 2016 Dec 21.
8
Diabetes and chronic kidney disease: concern, confusion, clarity?糖尿病与慢性肾脏病：担忧、困惑、明晰？
Can J Diabetes. 2014 Oct;38(5):287-9. doi: 10.1016/j.jcjd.2014.08.001.
9
Oral glucose lowering drugs in type 2 diabetic patients with chronic kidney disease.口服降糖药在慢性肾脏病 2 型糖尿病患者中的应用。
Hormones (Athens). 2013 Oct-Dec;12(4):483-94. doi: 10.14310/horm.2002.1436.
10
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.巴多昔芬甲基用于2型糖尿病和晚期慢性肾病
N Engl J Med. 2014 May 1;370(18):1768-9. doi: 10.1056/NEJMc1400872.

引用本文的文献

1
Amphiregulin in Fibrotic Diseases and Cancer.双调蛋白在纤维化疾病和癌症中的作用
Int J Mol Sci. 2025 Jul 19;26(14):6945. doi: 10.3390/ijms26146945.
2
High-fat/high-sucrose diet-induced renal changes in obese diabetic mice: a comparison with db/db and KK-Ay mice.高脂/高糖饮食诱导肥胖糖尿病小鼠的肾脏变化：与db/db和KK-Ay小鼠的比较。
J Vet Med Sci. 2025 Feb 1;87(2):138-146. doi: 10.1292/jvms.24-0313. Epub 2024 Dec 11.
3
Sodium-Glucose Cotransport Protein 2 Inhibitors in Patients With Type 2 Diabetes and Acute Kidney Disease.

本文引用的文献

1
Protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes.钠-葡萄糖共转运蛋白 2 抑制剂在伴有快速肾功能下降、G3 或 G4 期慢性肾脏病和 2 型糖尿病患者中的保护作用。
J Diabetes Investig. 2019 Nov;10(6):1510-1517. doi: 10.1111/jdi.13064. Epub 2019 May 17.
2
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.卡格列净与 2 型糖尿病和肾病患者的肾脏结局。
N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.
3
Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014.
钠-葡萄糖共转运蛋白 2 抑制剂在 2 型糖尿病合并急性肾损伤患者中的应用。
JAMA Netw Open. 2024 Jan 2;7(1):e2350050. doi: 10.1001/jamanetworkopen.2023.50050.
4
Intravenous injection of human umbilical cord-derived mesenchymal stem cells ameliorates not only blood glucose but also nephrotic complication of diabetic rats through autophagy-mediated anti-senescent mechanism.静脉注射人脐带间充质干细胞不仅通过自噬介导的抗衰老机制改善了糖尿病大鼠的血糖，还改善了其肾病并发症。
Stem Cell Res Ther. 2023 May 29;14(1):146. doi: 10.1186/s13287-023-03354-z.
5
Recent evidence in the etiology and treatment for diabetic kidney disease.近期糖尿病肾病病因与治疗的相关证据。
J Diabetes Investig. 2021 May;12(5):694-696. doi: 10.1111/jdi.13433. Epub 2020 Nov 15.
6
Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches.钠-葡萄糖协同转运蛋白2抑制剂的意义：来自2型糖尿病患者肾脏临床结局及基础研究的经验教训
Diabetol Int. 2020 Jun 11;11(3):245-251. doi: 10.1007/s13340-020-00444-8. eCollection 2020 Jul.
2014 年，日本 2 型糖尿病成年患者肾脏疾病临床表现的世代变化。
J Diabetes Investig. 2019 Jul;10(4):1032-1040. doi: 10.1111/jdi.12977. Epub 2019 Jan 1.
4
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.SGLT2 抑制剂用于 2 型糖尿病的心血管和肾脏结局的一级和二级预防：心血管结局试验的系统评价和荟萃分析。
Lancet. 2019 Jan 5;393(10166):31-39. doi: 10.1016/S0140-6736(18)32590-X. Epub 2018 Nov 10.
5
Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA-REG OUTCOME trial.恩格列净与心血管疾病合并 2 型糖尿病亚洲患者的肾脏结局：来自 EMPA-REG OUTCOME 试验的结果。
J Diabetes Investig. 2019 May;10(3):760-770. doi: 10.1111/jdi.12971. Epub 2019 Jan 7.
6
Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet.依帕列净改善高脂肪饮食诱导的肾小管线粒体异常。
J Diabetes Investig. 2018 Sep;9(5):1025-1032. doi: 10.1111/jdi.12802. Epub 2018 Mar 12.
7
Metabolomics window into diabetic complications.代谢组学揭示糖尿病并发症的奥秘。
J Diabetes Investig. 2018 Mar;9(2):244-255. doi: 10.1111/jdi.12723. Epub 2017 Sep 13.
8
Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.代谢记忆机制及肾缺氧作为糖尿病肾病的治疗靶点
J Diabetes Investig. 2017 May;8(3):261-271. doi: 10.1111/jdi.12624. Epub 2017 Mar 13.
9
Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.1988 - 2014年美国糖尿病成年人肾病的临床表现
JAMA. 2016 Aug 9;316(6):602-10. doi: 10.1001/jama.2016.10924.
10
Elevated expression levels of serum insulin-like growth factor-1, tumor necrosis factor-α and vascular endothelial growth factor 165 might exacerbate type 2 diabetic nephropathy.血清胰岛素样生长因子-1、肿瘤坏死因子-α和血管内皮生长因子165表达水平升高可能会加重2型糖尿病肾病。
J Diabetes Investig. 2017 Jan;8(1):108-114. doi: 10.1111/jdi.12542. Epub 2016 Jul 15.